E Strengman

2.6k total citations
9 papers, 337 citations indexed

About

E Strengman is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, E Strengman has authored 9 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in E Strengman's work include Genetic Associations and Epidemiology (3 papers), Circadian rhythm and melatonin (2 papers) and Cancer-related gene regulation (2 papers). E Strengman is often cited by papers focused on Genetic Associations and Epidemiology (3 papers), Circadian rhythm and melatonin (2 papers) and Cancer-related gene regulation (2 papers). E Strengman collaborates with scholars based in Netherlands, United States and Belgium. E Strengman's co-authors include Timon W. van Haeften, Cisca Wijmenga, Jana V. van Vliet‐Ostaptchouk, Ronit Shiri‐Sverdlov, Alexandra Zhernakova, Marten H. Hofker, Roel A. Ophoff, P. Pearson, Lodewijk A. Sandkuijl and H. van Someren and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Human Molecular Genetics.

In The Last Decade

E Strengman

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Strengman Netherlands 8 129 112 65 55 54 9 337
Galam Khan United States 12 124 1.0× 96 0.9× 25 0.4× 139 2.5× 104 1.9× 22 472
Ritesh Kaushal United States 10 198 1.5× 92 0.8× 29 0.4× 23 0.4× 70 1.3× 14 472
Ann V. Griffith United States 10 133 1.0× 50 0.4× 26 0.4× 68 1.2× 26 0.5× 16 460
Jean‐Christophe Devedjian France 5 137 1.1× 57 0.5× 95 1.5× 14 0.3× 59 1.1× 7 315
Péter Gergics Hungary 14 209 1.6× 134 1.2× 90 1.4× 32 0.6× 33 0.6× 29 501
Maria Varela United States 12 170 1.3× 112 1.0× 40 0.6× 20 0.4× 24 0.4× 19 421
Hanna Pisarek Poland 12 99 0.8× 46 0.4× 86 1.3× 69 1.3× 58 1.1× 51 468
Merel W. Boogaard Netherlands 10 195 1.5× 69 0.6× 69 1.1× 21 0.4× 48 0.9× 14 352
Sumiyasu Ishii Japan 14 183 1.4× 57 0.5× 124 1.9× 102 1.9× 30 0.6× 34 553
Joan E. Pellegrino United States 11 256 2.0× 215 1.9× 69 1.1× 13 0.2× 38 0.7× 19 492

Countries citing papers authored by E Strengman

Since Specialization
Citations

This map shows the geographic impact of E Strengman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Strengman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Strengman more than expected).

Fields of papers citing papers by E Strengman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Strengman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Strengman. The network helps show where E Strengman may publish in the future.

Co-authorship network of co-authors of E Strengman

This figure shows the co-authorship network connecting the top 25 collaborators of E Strengman. A scholar is included among the top collaborators of E Strengman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Strengman. E Strengman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Elias, Sjoerd G., Harm van Tinteren, Miangela M. Laclé, et al.. (2017). Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study. Annals of Oncology. 28(9). 2128–2134. 56 indexed citations
2.
Visser, Els, Lodewijk A.A. Brosens, Wendy W.J. de Leng, et al.. (2017). Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival. Diseases of the Esophagus. 30(9). 1–8. 3 indexed citations
3.
Luykx, Jurjen J., Loes M. Olde Loohuis, E Strengman, et al.. (2016). Peripheral blood gene expression profiles linked to monoamine metabolite levels in cerebrospinal fluid. Translational Psychiatry. 6(12). e983–e983. 13 indexed citations
4.
Jong, Steven de, Jurjen J. Luykx, E Strengman, et al.. (2014). Seasonal changes in gene expression represent cell-type composition in whole blood. Human Molecular Genetics. 23(10). 2721–2728. 30 indexed citations
5.
Luykx, Jurjen J., S C Bakker, Nan van Geloven, et al.. (2013). Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR. Translational Psychiatry. 3(10). e311–e311. 25 indexed citations
6.
Es, Michael A. van, Frank P. Diekstra, Jan H. Veldink, et al.. (2009). A CASE OF ALS-FTD IN A LARGE FALS PEDIGREE WITH A K17I ANG MUTATION. Neurology. 72(3). 287–288. 59 indexed citations
7.
Vliet‐Ostaptchouk, Jana V. van, Ronit Shiri‐Sverdlov, Alexandra Zhernakova, et al.. (2006). Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia. 50(1). 59–62. 94 indexed citations
8.
Sandkuijl, Lodewijk A., E Strengman, H. van Someren, et al.. (2003). A Genome-Wide Scan in Type 2 Diabetes Mellitus Provides Independent Replication of a Susceptibility Locus on 18p11 and Suggests the Existence of Novel Loci on 2q12 and 19q13. The Journal of Clinical Endocrinology & Metabolism. 88(5). 2223–2230. 45 indexed citations
9.
Sandkuijl, Lodewijk A., Lude Franke, E Strengman, et al.. (2003). Genome‐wide screen in obese pedigrees with type 2 diabetes mellitus from a defined Dutch population. European Journal of Clinical Investigation. 33(12). 1070–1074. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026